Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Health services and systems news

Show

From To
Are we losing our passion as AIDS activists?

We’ve come a long way since the days when fighting for LGBT rights demanded action such as the Stonewall Riots. Or a critical need for HIV medications prompted protests blocking traffic on the Golden Gate Bridge. Are we finished? Have the communities and people affected by HIV and AIDS fought hard enough, and is the job of AIDS activists near an end?

Published
16 August 2016
From
BETA blog
As Trump Vice President, Mike Pence Would Be a Nightmare for People With HIV

There is nothing in Mike Pence's statements or actions to suggest that he has learned anything from the HIV outbreak that ran rampant through Scott County, Indiana, when he governed the state. As one indication of his HIV priorities, his advocacy for LGBT conversion therapy while in the U.S. House of Representatives included proposing that the Ryan White Care Act be reauthorized only if monies were redirected towards organizations "which provide assistance to those seeking to change their sexual behavior."

Published
15 August 2016
From
The Body
Gilead bags Genmab tech to develop bispecific antibody against HIV

Gilead has struck a deal to access bispecific antibody technology from Genmab. The agreement gives Gilead an exclusive license to use the Danish drugmaker’s bispecific platform to create an HIV therapeutic, plus an option to take up another exclusive license on the technology.

Published
12 August 2016
From
FierceBiotech
Do trade deals threaten India as low-cost HIV drug maker?

We wondered if it’s true that the next round of agreements, both those that involve the United States and those that don’t, would undermine some large drug makers in India.

Published
09 August 2016
From
Politifact
Rhetoric meets reality: ending HIV and AIDS

Ending AIDS by 2030 is redundant rhetoric. It is meaningless without investment in community participation.

Published
09 August 2016
From
Open Democracy
Package of prophylaxis against infections reduces the risk of death for people starting HIV treatment very late

A package of enhanced prophylaxis against infections significantly reduced the risk of death in adults and children with advanced HIV disease after starting antiretroviral treatment in a

Published
08 August 2016
By
Keith Alcorn
Ending AIDS by 2030 a distant prospect, global HIV incidence, prevalence, treatment coverage and mortality figures suggest

Remarkable progress has been made towards curbing the global HIV epidemic, but there is little chance of achieving the UNAIDS goal of “ending AIDS” by 2030, according to

Published
07 August 2016
By
Michael Carter
HIV is back on the front pages

At The King's Fund, we have argued for empowering local services to reform from within rather than relying on top-down direction, regulation or market forces to deliver high-quality care. The dispute over the funding of antiretroviral drugs for prevention illustrates the challenges of doing this in the absence of an effective strategic and integrated approach to commissioning, especially when the structures are so complex and the relationship between local decisions and national strategy so loosely defined.

Published
03 August 2016
From
The King's Fund
Brexit: What does it mean for development aid and the Global Fund?

Britain’s vote to leave the European Union has left much of the global development community wondering what this will mean for the UK’s role as a global leader in international aid and development. It also raises issues about the implications for the Global Fund’s Fifth Replenishment.

Published
03 August 2016
From
Global Fund Observer
PrEP rationing is symptomatic of NHS bid to cut costs, at all costs

NHS England’s setback in the high court over its attempt to get one set of cash-strapped public bodies (local councils) to foot the £10m-£20m a year bill for PrEP treatment rather than another – itself – is the latest manifestation of the health service’s increasing efforts to reduce the number of treatments it pays for, or the number of patients who receive them, or both.

Published
03 August 2016
From
The Guardian

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close